Genomtec is advancing its M&A process, achieving major cost reductions and technology improvements in genetic diagnostics. The company is progressing with funded projects and targets strategic partnerships, with its competitive, low-cost platform positioned for growth in the expanding diagnostics market.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.